Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05931783 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Artery

Study acronym: HARVITA
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 1, 2023 to Mar 12, 2024
    • Site details revised at 8 of 8 sites
    v3
  2. Start date: Aug 1, 2023 to Oct 1, 2023v2 Show 7 more changesShow less
    • Primary endpoint revised
    • Enrollment target: 1300 to 1350
    • Study sites: 7 to 8
    • Primary completion date: Aug 1, 2028 to Oct 1, 2028
    • Study completion date: Aug 1, 2031 to Oct 1, 2031
    • Secondary endpoint revised
    • Eligibility criteria expanded, about 5 words
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Internal thoracic arteries can be harvested in skeletonized or pedicled technique. Latest research has posed a potential adverse effect of skeletonizing the internal thoracic arteries on graft patency rates and clinical outcome. Prospective, randomized, multi-centre trials are necessary to investigate the impact of harvesting technique of left internal thoracic artery (LITA) on graft patency rates and clinical outcome after coronary artery bypass grafting. The HARVITA trial compares skeletonized and pedicled harvesting technique of LITA regarding graft patency rates and patient survival.
Trial Details
NCT Number NCT05931783
Lead Sponsor Medical University Innsbruck
Conditions
(from sponsor)		 Coronary Artery Disease
Related terms Coronary Artery Disease
Enrollment 1,350 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov